ISRAEL 
HIGH-TECH & INVESTMENT REPORT

from the December 2004 issue


Bandage Using Peptides and Collagen Heals Wounds and Regenerates Tissue


Hapto-Biotech, an Israeli start-up company, and New York-based Ortec International Inc., have joined forces to develop a bandage capable of healing wounds and regenerating tissue. The method employs a unique combination of peptides and collagen.

The new technology could also have an important impact on orthopedic and dental procedures.

The active peptides were developed by Hapto, a start-up company established by Hadasit Medical Research and Development Ltd., the commercial subsidiary of the Hadassah Medical Organization. The collagen-based biomaterial was developed by Ortec. The Hapto-Ortec collaboration is the second stage of a joint research project the two companies began in 2002, the results of which produced the potential for the biotech bandage.

This joint venture is an important landmark in our company's development plan," said Ira Weinstein, Hapto-Biotech CEO. "I am confident that during the next 24 months, we will make significant progress in the development of the biotech bandage, which will move us even further ahead," he said, anticipating positive results from clinical trials on humans, being conducted at the present time.

Haptide, Hapto's core technology, utilizes proprietary synthetic peptides that mimic the mechanism of cell attachment to fibrin. It was developed by Dr. Raphael Gorodetsky of Hadassah and Dr. Gerard Marx of Hapto.


Reprinted from the Israel High-Tech & Investment Report December 2004

Click HERE to request further information.
Click HERE to go BACK.